WO2024236544 - PET TRACER COMPOUNDS FOR TRACING ALPHA-GALACTOSIDASE A AND REACTION INTERMEDIATES, AND METHODS OF USE
National phase entry is expected:
Publication Number
WO/2024/236544
Publication Date
21.11.2024
International Application No.
PCT/IB2024/054827
International Filing Date
17.05.2024
Title **
[English]
PET TRACER COMPOUNDS FOR TRACING ALPHA-GALACTOSIDASE A AND REACTION INTERMEDIATES, AND METHODS OF USE
[French]
COMPOSÉS TRACEURS POUR TEP DESTINÉS AU SUIVI D'ALPHA-GALACTOSIDASE A ET D'INTERMÉDIAIRES DE RÉACTION ET MÉTHODES D'UTILISATION
Applicants **
TAKEDA PHARMACEUTICAL COMPANY LIMITED
Inventors
LOHITH, Talakad
MCQUADE, Paul
NARAYANAN, Sarav
ISLAM, Rizwana
KAITTANIS, Charalambos
Priority Data
63/502,761
17.05.2023
US
63/573,324
02.04.2024
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 3487 | |
| EPO | Filing, Examination, Granting | 25583 | |
| Japan | Filing, Examination, Granting | 3081 | |
| South Korea | Filing, Examination, Granting | 3990 | |
| USA | Filing, Examination, Granting | 11390 |
Total:
47,531
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Contact Us
Abstract[English]
-galactosidase A gene therapy or after an enzyme replacement therapy.[French]
-galactosidase A ou après une thérapie de remplacement enzymatique.